Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9.
Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis worldwide, and is thought to be immune-mediated. It is preceded by upper respiratory or gastrointestinal infection in about two-thirds of cases and is associated with some viral infections, including influenza. GBS has also been associated with the 1976 swine-influenza vaccine. Thereafter, some studies have shown a small increased risk of GBS following receipt of seasonal and 2009 H1N1 monovalent influenza vaccines. Studies over the years have also shown an increased risk of GBS following influenza infection, and the magnitude of risk is several times greater than that following influenza vaccination. Because GBS is rare, and even rarer following vaccination, it is difficult to estimate precise risk. We try to shed light on the complex relationship of GBS and its association with influenza and influenza vaccines over the past 35 years.
格林-巴利综合征(GBS)是全世界最常见的急性弛缓性瘫痪病因,被认为是免疫介导的疾病。大约三分之二的病例在发病前有上呼吸道或胃肠道感染,与某些病毒感染有关,包括流感。GBS 也与 1976 年的猪流感疫苗有关。此后,一些研究表明,季节性和 2009 年 H1N1 单价流感疫苗接种后,GBS 的发病风险略有增加。多年来的研究还表明,流感感染后 GBS 的发病风险增加,风险幅度比流感疫苗接种后高出数倍。由于 GBS 较为罕见,接种疫苗后更为罕见,因此很难准确估计风险。我们试图在过去 35 年中阐明 GBS 与其与流感和流感疫苗的复杂关系。